α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6

被引:229
作者
Wu, Zhijian
Miller, Edward
Agbandje-McKenna, Mavis
Samulski, Richard Jude
机构
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
[2] Univ Florida, Coll Med, Dept Biochem & Mol Biol, McKnight Brain Inst,Ctr Struct Biol, Gainesville, FL 32610 USA
关键词
D O I
10.1128/JVI.00895-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recombinant adeno-associated viruses (AAVs) are promising vectors in the field of gene therapy. Different AAV serotypes display distinct tissue tropism, believed to be related to the distribution of their receptors on target cells. Of the 11 well-characterized AAV serotypes, heparan sulfate proteoglycan and sialic acid have been suggested to be the attachment receptors for AAV type 2 and types 4 and 5, respectively. In this report, we identify the receptor for the two closely related serotypes, AAV1 and AAV6. First, we demonstrate using coinfection experiments and luciferase reporter analysis that AAV1 and AAV6 compete for similar receptors. Unlike heparin sulfate, enzymatic or genetic removal of sialic acid markedly reduced AAV1 and AAV6 binding and transduction. Further analysis using lectin staining and lectin competition assays identified that AAV1 and AAV6 use either alpha 2,3-linked or alpha 2,6-linked sialic acid when transducing numerous cell types (HepG2, Pro-5, and Cos-7). Treatment of cells with proteinase K but not glycolipid inhibitor reduced AAV1 and AAV6 infection, supporting the hypothesis that the sialic acid that facilitates infection is associated with glycoproteins rather than glycolipids. In addition, we determined by inhibitor (N-benzyl GalNAc)- and cell line-specific (Lec-1) studies that AAV1 and AAV6 require N-linked and not O-linked sialic acid. Furthermore, a resialylation experiment on a deficient Lec-2 cell line confirmed a 2,3 and 2,6 N-linked sialic acid requirement, while studies of mucin with O-linked sialic acid showed no inhibition effect for AAV1 and AAV6 transduction on Cos-7 cells. Finally, using a glycan array binding assay we determined that AAV1 efficiently binds to NeuAc alpha 2-3GalNAc beta 1-4GlcNAc, as well as two glycoproteins with alpha 2,3 and alpha 2,6 N-linked sialic acids. Taken together, competition, genetic, inhibitor, enzymatic reconstitution, and glycan array experiments support alpha 2,3 and alpha 2,6 sialic acids that are present on N-linked glycoproteins as primary receptors for efficient AAV1 and AAV6 viral infection.
引用
收藏
页码:9093 / 9103
页数:11
相关论文
共 48 条
[1]   CHARACTERIZATION OF THE DNA OF A DEFECTIVE HUMAN PARVOVIRUS ISOLATED FROM A GENITAL SITE [J].
BANTELSCHAAL, U ;
HAUSEN, HZ .
VIROLOGY, 1984, 134 (01) :52-63
[2]   Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6 [J].
Blankinship, MJ ;
Gregorevic, P ;
Allen, JM ;
Harper, SQ ;
Harper, H ;
Halbert, CL ;
Miller, AD ;
Chamberlain, JS .
MOLECULAR THERAPY, 2004, 10 (04) :671-678
[3]   Printed covalent glycan array for ligand profiling of diverse glycan binding proteins [J].
Blixt, O ;
Head, S ;
Mondala, T ;
Scanlan, C ;
Huflejt, ME ;
Alvarez, R ;
Bryan, MC ;
Fazio, F ;
Calarese, D ;
Stevens, J ;
Razi, N ;
Stevens, DJ ;
Skehel, JJ ;
van Die, I ;
Burton, DR ;
Wilson, IA ;
Cummings, R ;
Bovin, N ;
Wong, CH ;
Paulson, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17033-17038
[4]   Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors [J].
Chao, HJ ;
Liu, YB ;
Rabinowitz, J ;
Li, CW ;
Samulski, RJ ;
Walsh, CE .
MOLECULAR THERAPY, 2000, 2 (06) :619-623
[5]   Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors [J].
Chen, SF ;
Kapturczak, M ;
Loiler, SA ;
Zolotukhin, S ;
Glushakova, OY ;
Madsen, KM ;
Samulski, RJ ;
Hauswirth, WW ;
Campbell-Thompson, M ;
Berns, KI ;
Flotte, TR ;
Atkinson, MA ;
Tisher, CC ;
Agarwal, A .
HUMAN GENE THERAPY, 2005, 16 (02) :235-247
[6]   AAV hybrid serotypes: Improved vectors for gene delivery [J].
Choi, VW ;
McCarty, DM ;
Samulski, RJ .
CURRENT GENE THERAPY, 2005, 5 (03) :299-310
[7]   Identification of PDGFR as a receptor for AAV-5 transduction [J].
Di Pasquale, G ;
Davidson, BL ;
Stein, CS ;
Martins, IS ;
Scudiero, D ;
Monks, A ;
Chiorini, JA .
NATURE MEDICINE, 2003, 9 (10) :1306-1312
[8]   Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5 [J].
DiMattia, M ;
Govindasamy, L ;
Levy, HC ;
Gurda-Whitaker, B ;
Kalina, A ;
Kohlbrenner, E ;
Chiorini, JA ;
McKenna, R ;
Muzyczka, N ;
Zolotukhin, S ;
Agbandje-Mckenna, M .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2005, 61 :917-921
[9]   Intracellular trafficking of adeno-associated viral vectors [J].
Ding, W ;
Zhang, L ;
Yan, Z ;
Engelhardt, JF .
GENE THERAPY, 2005, 12 (11) :873-880
[10]   Human-specific regulation of α2-6-linked sialic acids [J].
Gagneux, P ;
Cheriyan, M ;
Hurtado-Ziola, N ;
van der Linden, ECMB ;
Anderson, D ;
McClure, H ;
Varki, A ;
Varki, NM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (48) :48245-48250